Elekta’s Project Atlantic: A New Blue Ocean For Radiation Therapy
This article was originally published in The Gray Sheet
The firm's so-called Project Atlantic radiation therapy system combines high-field real-time MR imaging with state-of-the-art linear technology that Elekta says will take the standard of care to the next level. It is aiming for European and U.S. approvals in 2017.
You may also be interested in...
In recent interview, CEO Blake Cadwell talked about Soundly’s business model and outlook for hearing aid marketplace after FDA's pending publication of rule aiming to make the devices more accessible. Firm since June has offered online testing and advice for customers about hearing aids best suited for their needs.
Revlon approved for $1.4bn debtor-in-possession financing from BrandCo Lenders, a group of operating subsidiaries formed in capital structure changes which owns much of Revlon’s intellectual property. Firm appoints interim CFO to set course for debt restructuring.
Keeping Track: Enhertu Brings Anti-HER2 Therapy To Lung Cancer; Novaliq Platform Supports Two Dry Eye NDAs
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.